The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella.
Genetically defined, live attenuated Salmonella vaccines are proving useful both as oral vaccines against salmonellosis and for the development of multivalent vaccines based on the expression of heterologous antigens in such strains. Several candidate attenuated S. typhi strains are at present being evaluated as new single dose oral typhoid vaccines in human volunteers. The emergence of such a vaccine will facilitate the development of multivalent vaccines for humans. Many antigens from different infectious organisms have been expressed in attenuated Salmonella. A focus of this work has been on developing vaccines against parasitic diseases. This review will summarize the efforts that have been made in this area.
Chatfield
S N
SN
Medeva Vaccine Research Unit, Imperial College of Science Technology and Medicine, London, UK.
Roberts
M
M
Dougan
G
G
Hormaeche
C
C
Khan
C M
CM
D000284:Administration, Oral; D000818:Animals; D001428:Bacterial Vaccines / Q000008:administration & dosage; D006801:Humans; D010272:Parasitic Diseases / Q000276:immunology* / Q000517:prevention & control*; D012475:Salmonella; D012480:Salmonella Infections / Q000276:immunology / Q000517:prevention & control*; D012485:Salmonella typhi / Q000276:immunology*; D014435:Typhoid Fever / Q000276:immunology / Q000517:prevention & control*; D014613:Vaccines, Attenuated / Q000008:administration & dosage
D001428:Bacterial Vaccines; D014613:Vaccines, Attenuated